Table 2.
Type of outcome | Outcome | N | % |
---|---|---|---|
| |||
Respiratory | Ever wheeze (symptom of asthma) | 97 | 32 |
Current* wheeze (symptom of asthma) † | 62 | 20 | |
Current symptoms of severe asthma‡ | 33 | 11 | |
Ever doctor-diagnosed asthma† | 37 | 12 | |
Current dry cough† | 118 | 39 | |
Ever LRTI | 49 | 16 | |
Current LRTI† | 15 | 5 | |
Allergic | Ever nasal allergies (allergic rhinitis) | 67 | 22 |
Current nasal allergies (allergic rhinitis) † | 63 | 21 | |
Current allergic rhinoconjunctivitis | 42 | 14 | |
Ever itchy rash (symptom of eczema) | 52 | 17 | |
Current itchy rash (symptom of eczema) † | 39 | 13 | |
Ever doctor-diagnosed eczema† | 21 | 7 | |
Current medication for eczema | 8 | 3 |
Past 12 months.
Selected for epidemiological analysis.
≥4 attacks of wheeze, or >1 night per week sleep disturbance from wheeze, or wheeze affecting speech in the past 12 months.
ISA, Infants’ Environmental Health Study; LRTI, lower respiratory tract infection.